As conversations around treatments like ketamine and esketamine (Spravato) continue to expand, many patients and providers are asking a crucial question: can ketamine treat depression, anxiety, and trauma disorders in a durable way?

Marni Chanoff had the opportunity to join colleagues from Cambridge Health Alliance and Harvard Medical School for a conference focused on psychedelic-assisted psychotherapy to present our integrative and collaborative KAP model of care.